Pharmacoepidemiology, impacts of anxiety disorders and anxiolytic abuse before and during the COVID-19 pandemic. Research, Society and Development, [S. l.], v. 11, n. 5, p. e36111528340, 2022. DOI: 10.33448/rsd-v11i5.28340. Disponível em: https://rsdjournal.org/rsd/article/view/28340. Acesso em: 5 dec. 2025.